Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-02

FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for rabeprazole sodium from Torrent Pharmaceuticals Limited under ANDA 202376, indicating a post-approval change for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabeprazole sodium (rabeprazole)

Snippet

SUPPL AP for RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM)